These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 901724)

  • 1. A comparison of three different enzyme inducing agents and their influence on plasma lipids in man [proceedings].
    Ohnhaus EE
    Br J Clin Pharmacol; 1977 Jun; 4(3):398P. PubMed ID: 901724
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
    Ohnhaus EE; Kirchhof B; Peheim E
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
    [No Abstract]   [Full Text] [Related]  

  • 4. Divergent effects of different enzyme-inducing agents on endogenous and exogenous testosterone.
    Bammel A; van der Mee K; Ohnhaus EE; Kirch W
    Eur J Clin Pharmacol; 1992; 42(6):641-4. PubMed ID: 1623905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative investigations of the enzyme-inducing activity of rifampicin and barbiturates in man.
    Nitti V; Ninni A; Meola G; Iuliano A; Curci G
    Chemotherapy; 1973 Oct; 19(4):206-10. PubMed ID: 4772960
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-dependent enzyme induction.
    Breckenridge A; Orme ML; Davies L; Thorgeirsson SS; Davies DS
    Clin Pharmacol Ther; 1973; 14(4):514-20. PubMed ID: 4723259
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interactions between phenprocoumon (Marcumar) and drug-catabolizing, enzyme system-inducing pharmaceutic agents].
    Heni N; Völger R; Glogner P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1579-82. PubMed ID: 347786
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculosis therapy and enzyme induction in man.
    Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.
    Heller FR; Desager JP; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):138-42. PubMed ID: 3410596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme induction and renal function in man.
    Ohnhaus EE; Martin J; Kinser J; Colombo JP
    Br J Clin Pharmacol; 1977 Feb; 4(1):33-7. PubMed ID: 843422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent enzyme induction.
    Breckenridge A; Davies DS; Davies L; Orme M
    Br J Pharmacol; 1973 Mar; 47(3):616P-617P. PubMed ID: 4730838
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Drugs affecting oral contraceptives.
    Mumford JP
    Br Med J; 1974 May; 2(5914):333-4. PubMed ID: 4827122
    [No Abstract]   [Full Text] [Related]  

  • 15. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
    Larousse C; Kergueris MF; Le Normand Y; Visset J
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired enzyme induction by rifampicin in the elderly.
    Twum-Barima Y; Finnigan T; Habash AI; Cape RD; Carruthers SG
    Br J Clin Pharmacol; 1984 May; 17(5):595-7. PubMed ID: 6733008
    [No Abstract]   [Full Text] [Related]  

  • 17. Inductive effects of rifapentine on mice hepatic mixed function oxidase system.
    Liu DY; Wang YS
    Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):109-13. PubMed ID: 2319833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofibrate and enzymatic induction in man.
    Houin G; Tillement JP
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):150-4. PubMed ID: 649234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL; Chang T; Jaffe JM
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
    Maddocks JL; Wake CJ; Harber MJ
    Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.